Perkins Capital Management Decreased Its Atricure (ATRC) Position; Abercrombie & Fitch Co (ANF) Sentiment Is 1.24

February 3, 2018 - By Hazel Jackson

Perkins Capital Management Inc decreased Atricure Inc (ATRC) stake by 31.34% reported in 2017Q3 SEC filing. Perkins Capital Management Inc sold 42,418 shares as Atricure Inc (ATRC)’s stock rose 23.67%. The Perkins Capital Management Inc holds 92,950 shares with $2.08M value, down from 135,368 last quarter. Atricure Inc now has $560.20 million valuation. The stock decreased 1.52% or $0.25 during the last trading session, reaching $16.25. About 159,269 shares traded. AtriCure, Inc. (NASDAQ:ATRC) has risen 53.35% since February 3, 2017 and is uptrending. It has outperformed by 36.65% the S&P500.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer. The company has market cap of $1.40 billion. The Firm operates through two divisions, Abercrombie and Hollister. It currently has negative earnings. It offers knit tops, woven shirts, graphic T-shirts, fleece, sweaters, jeans, woven pants, shorts, outerwear, dresses, intimates, and swimwear; and personal care products and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, Hollister, and Gilly Hicks brand names.

Analysts await Abercrombie & Fitch Co. (NYSE:ANF) to report earnings on March, 1. They expect $0.85 earnings per share, up 19.72% or $0.14 from last year’s $0.71 per share. ANF’s profit will be $57.89M for 6.04 P/E if the $0.85 EPS becomes a reality. After $0.30 actual earnings per share reported by Abercrombie & Fitch Co. for the previous quarter, Wall Street now forecasts 183.33% EPS growth.

The stock increased 0.10% or $0.02 during the last trading session, reaching $20.54. About 2.71 million shares traded. Abercrombie & Fitch Co. (ANF) has declined 47.82% since February 3, 2017 and is downtrending. It has underperformed by 64.52% the S&P500.

Ratings analysis reveals 9% of Abercrombie & Fitch’s analysts are positive. Out of 11 Wall Street analysts rating Abercrombie & Fitch, 1 give it “Buy”, 3 “Sell” rating, while 7 recommend “Hold”. The lowest target is $13.0 while the high is $21.0. The stock’s average target of $17.60 is -14.31% below today’s ($20.54) share price. ANF was included in 12 notes of analysts from August 30, 2016. The rating was downgraded by Wolfe Research on Monday, November 14 to “Peer Perform”. The firm earned “Hold” rating on Wednesday, August 31 by Stifel Nicolaus. Standpoint Research upgraded Abercrombie & Fitch Co. (NYSE:ANF) on Tuesday, August 30 to “Buy” rating. The rating was maintained by FBR Capital with “Mkt Perform” on Wednesday, August 31. Mizuho maintained Abercrombie & Fitch Co. (NYSE:ANF) on Tuesday, August 30 with “Neutral” rating. Telsey Advisory maintained Abercrombie & Fitch Co. (NYSE:ANF) rating on Wednesday, August 31. Telsey Advisory has “Market Perform” rating and $21.0 target. RBC Capital Markets maintained Abercrombie & Fitch Co. (NYSE:ANF) rating on Wednesday, August 31. RBC Capital Markets has “Sector Perform” rating and $20.0 target. KeyBanc Capital Markets downgraded Abercrombie & Fitch Co. (NYSE:ANF) on Thursday, October 6 to “Sector Weight” rating. Oppenheimer downgraded Abercrombie & Fitch Co. (NYSE:ANF) on Tuesday, January 3 to “Underperform” rating. The firm has “Underperform” rating by FBR Capital given on Tuesday, November 15.

Sls Management Llc holds 13.09% of its portfolio in Abercrombie & Fitch Co. for 695,714 shares. Lesa Sroufe & Co owns 369,324 shares or 4.67% of their US portfolio. Moreover, Quinn Opportunity Partners Llc has 3.04% invested in the company for 1.34 million shares. The Colorado-based Paradice Investment Management Llc has invested 2.75% in the stock. Lorber David A, a Connecticut-based fund reported 8,708 shares.

Analysts await AtriCure, Inc. (NASDAQ:ATRC) to report earnings on February, 27. They expect $-0.21 EPS, up 22.22% or $0.06 from last year’s $-0.27 per share. After $-0.22 actual EPS reported by AtriCure, Inc. for the previous quarter, Wall Street now forecasts -4.55% EPS growth.

Investors sentiment increased to 2.03 in 2017 Q3. Its up 0.78, from 1.25 in 2017Q2. It improved, as 9 investors sold ATRC shares while 21 reduced holdings. 23 funds opened positions while 38 raised stakes. 26.77 million shares or 5.51% more from 25.37 million shares in 2017Q2 were reported. 334,565 are owned by Citadel Ltd Liability Company. Wellington Mgmt Grp Llp has 0.02% invested in AtriCure, Inc. (NASDAQ:ATRC) for 3.77M shares. Ny State Common Retirement Fund holds 33,100 shares. Moreover, Quantum Mgmt has 0.25% invested in AtriCure, Inc. (NASDAQ:ATRC). Legal & General Gp Public Ltd Company has invested 0% in AtriCure, Inc. (NASDAQ:ATRC). Paradigm Capital Management has invested 0.08% of its portfolio in AtriCure, Inc. (NASDAQ:ATRC). Eventide Asset Management Ltd holds 0.23% or 180,000 shares in its portfolio. Great West Life Assurance Can reported 0% in AtriCure, Inc. (NASDAQ:ATRC). Horan Capital Ltd Liability Company has invested 0% in AtriCure, Inc. (NASDAQ:ATRC). Cortina Asset Mngmt Lc reported 440,072 shares. 13,000 were reported by Ubs Asset Americas. Manufacturers Life Insurance The holds 25,001 shares or 0% of its portfolio. Wasatch Advsrs owns 423,963 shares for 0.13% of their portfolio. Geode Capital Mgmt Ltd Liability Corp holds 275,825 shares. Jpmorgan Chase & Com accumulated 34,465 shares or 0% of the stock.